Literature DB >> 24107312

The NOD2 receptor does not play a major role in the pathogenesis of Group B Streptococcus in mice.

Paul Lemire1, Cynthia Calzas, Mariela Segura.   

Abstract

Group B Streptococcus (GBS) capsular type III is an important agent of life-threatening invasive infections. It has been previously shown that encapsulated GBS is easily internalized by dendritic cells (DCs) and this internalization has an impact on cytokine production. The intracellular receptors or pathways underlying this response are not well understood. In this work, we investigated the role of NOD2 in the pathogenesis of GBS using a mouse model of infection. NOD2(-/-) mice showed similar levels of survival and bacteremia than control mice. Interestingly, ex vivo analysis of total spleen cells from infected animals showed that the absence of NOD2 results in reduced production of inflammatory cytokines. However this abridged inflammatory response does not seem to improve mouse survival. In conclusion, we demonstrated that NOD2 is not a crucial receptor to fight GBS infection and only partially contributes to the inflammatory response.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  CPS; DCs; GBS; Group B Streptococcus; Inflammatory cytokines; NLR family pyrin domain-containing protein 3; NLRP3; NLRs; NOD1; NOD2; Pathogenesis; TLR; capsular polysaccharide; dendritic cells; nod-like receptors; nucleotide-binding oligomerization domain-containing protein 1; nucleotide-binding oligomerization domain-containing protein 2; toll-like receptor

Mesh:

Substances:

Year:  2013        PMID: 24107312     DOI: 10.1016/j.micpath.2013.09.006

Source DB:  PubMed          Journal:  Microb Pathog        ISSN: 0882-4010            Impact factor:   3.738


  8 in total

1.  Vimentin Regulates Chemokine Expression and NOD2 Activation in Brain Endothelium during Group B Streptococcal Infection.

Authors:  R Villarreal; H S Manzer; A M Keestra-Gounder; K S Doran
Journal:  Infect Immun       Date:  2021-09-07       Impact factor: 3.441

2.  Implication of TLR- but not of NOD2-signaling pathways in dendritic cell activation by group B Streptococcus serotypes III and V.

Authors:  Paul Lemire; David Roy; Nahuel Fittipaldi; Masatoshi Okura; Daisuke Takamatsu; Eugenia Bergman; Mariela Segura
Journal:  PLoS One       Date:  2014-12-01       Impact factor: 3.240

3.  Group B Streptococcus Induces a Robust IFN-γ Response by CD4(+) T Cells in an In Vitro and In Vivo Model.

Authors:  Damian Clarke; Corinne Letendre; Marie-Pier Lecours; Paul Lemire; Tristan Galbas; Jacques Thibodeau; Mariela Segura
Journal:  J Immunol Res       Date:  2016-02-16       Impact factor: 4.818

Review 4.  Group B Streptococcal Maternal Colonization and Neonatal Disease: Molecular Mechanisms and Preventative Approaches.

Authors:  Kathryn A Patras; Victor Nizet
Journal:  Front Pediatr       Date:  2018-02-22       Impact factor: 3.418

5.  Natural Killer Cell Functions during the Innate Immune Response to Pathogenic Streptococci.

Authors:  Paul Lemire; Tristan Galbas; Jacques Thibodeau; Mariela Segura
Journal:  Front Microbiol       Date:  2017-06-29       Impact factor: 5.640

6.  Evaluation of the Immunomodulatory Properties of Streptococcus suis and Group B Streptococcus Capsular Polysaccharides on the Humoral Response.

Authors:  Cynthia Calzas; Morgan Taillardet; Insaf Salem Fourati; David Roy; Marcelo Gottschalk; Hugo Soudeyns; Thierry Defrance; Mariela Segura
Journal:  Pathogens       Date:  2017-04-20

Review 7.  Inflammasome/IL-1β Responses to Streptococcal Pathogens.

Authors:  Christopher N LaRock; Victor Nizet
Journal:  Front Immunol       Date:  2015-10-08       Impact factor: 7.561

8.  Genomic Recombination Leading to Decreased Virulence of Group B Streptococcus in a Mouse Model of Adult Invasive Disease.

Authors:  Sarah Teatero; Paul Lemire; Ken Dewar; Jessica Wasserscheid; Cynthia Calzas; Gustavo V Mallo; Aimin Li; Taryn B T Athey; Mariela Segura; Nahuel Fittipaldi
Journal:  Pathogens       Date:  2016-08-05
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.